Sant Feliu de Guixols, Spain

Xavier Leon-madrenas

This inventor holds 1 USPTO granted patent. Top assignees: Esteve Pharmaceuticals, S.a., Universität Autonoma De Barcelona. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xavier Leon-madrenas. Retrieved from https://idiyas.com/inventor/xavier-leon-madrenas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xavier Leon-Madrenas: Innovator in Gene Therapy

Introduction

Xavier Leon-Madrenas is a notable inventor based in Sant Feliu de Guixols, Spain. He has made significant contributions to the field of gene therapy through his innovative methods for producing recombinant viral vectors. His work is particularly focused on recombinant AAV vectors, which are essential for effective gene therapy applications.

Latest Patents

Leon-Madrenas holds a patent titled "Methods for the manufacture of recombinant viral vectors." This invention relates to techniques for producing high titer recombinant viral vectors, enabling their practical application in gene therapy. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Xavier has worked with esteemed organizations such as Esteve Pharmaceuticals and Universitat Autonoma de Barcelona. His experience in these institutions has allowed him to develop and refine his innovative methods in the field of biotechnology.

Collaborations

Leon-Madrenas has collaborated with notable colleagues, including Francesc Godia-Casablancas and Maria-Fàtima Bosch-Tubert. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.

Conclusion

Xavier Leon-Madrenas is a pioneering inventor whose work in recombinant viral vectors is paving the way for advancements in gene therapy. His contributions are vital to the ongoing development of effective therapeutic techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…